The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Aerosol Deposition in Health and Disease
Open accessAbstract
The success of inhalation therapy is not only dependent upon the pharmacology of the drugs being inhaled but also upon the site and extent of deposition in the respiratory tract. This article reviews the main mechanisms affecting the transport and deposition of inhaled aerosol in the human lung. Aerosol deposition in both the healthy and diseased lung is described mainly based on the results of human studies using nonimaging techniques. This is followed by a discussion of the effect of flow regime on aerosol deposition. Finally, the link between therapeutic effects of inhaled drugs and their deposition pattern is briefly addressed. Data show that total lung deposition is a poor predictor of clinical outcome, and that regional deposition needs to be assessed to predict therapeutic effectiveness. Indeed, spatial distribution of deposited particles and, as a consequence, drug efficiency is strongly affected by particle size. Large particles (>6 μm) tend to mainly deposit in the upper airway, limiting the amount of drugs that can be delivered to the lung. Small particles (<2 μm) deposit mainly in the alveolar region and are probably the most apt to act systemically, whereas the particle in the size range 2-6 μm are be best suited to treat the central and small airways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deposition of particles in the human respiratory tract in the size range 0.005–15 μm
Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., & Stahlhofen, W. (1986) · Journal of Aerosol Science · doi:10.1016/0021-8502(86)90035-2 · Cited by 1,026
What the pulmonary specialist should know about the new inhalation therapies
Laube, B. L., Janssens, H. M., de Jongh, F. H. C., Devadason, S. G., Dhand, R., Diot, P., Everard, M. L., Horvath, I., Navalesi, P., Voshaar, T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00166410 · Cited by 806
Regional Lung Deposition and Bronchodilator Response as a Function of β 2 -Agonist Particle Size
Usmani, O. S., Biddiscombe, M. F., & Barnes, P. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1414oc · Cited by 578
Intercomparison of experimental regional aerosol deposition data
STAHLHOFEN, W., RUDOLF, G., & JAMES, A. C. (1989) · Journal of Aerosol Medicine · doi:10.1089/jam.1989.2.285 · Cited by 423
Kim, C. S., & Kang, T. C. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117024 · Cited by 189
The Expanding Role of Aerosols in Systemic Drug Delivery, Gene Therapy, and Vaccination
Laube, B. L. (2005) · Respiratory Care · doi:10.4187/respcare.05501161 · Cited by 176
Total deposition of aerosol particles in the human respiratory tract for nose and mouth breathing
Heyder, J., Armbruster, L., Gebhart, J., Grein, E., & STAHLHOFEN, W. (1975) · Journal of Aerosol Science · doi:10.1016/0021-8502(75)90020-8 · Cited by 153
Zanen, P., Go, L. T., & Lammers, J. J. (1996) · Thorax · doi:10.1136/thx.51.10.977 · Cited by 150
Regional deposition of 2.5–7.5 μm diameter inhaled particles in healthy male non-smokers
Foord, N., BLACK, A. E., & Walsh, M. T. (1978) · Journal of Aerosol Science · doi:10.1016/0021-8502(78)90037-x · Cited by 138
Convective mixing in human respiratory tract: estimates with aerosol boli
Heyder, J., Blanchard, J. D., Feldman, H. A., et al. (1988) · Journal of Applied Physiology · doi:10.1152/jappl.1988.64.3.1273 · Cited by 137
Cited by
Airborne transmission of respiratory viruses
Wang, C. C., Prather, K. A., Sznitman, J., Jimenez, J. L., Lakdawala, S. S., Tufekci, Z., & Marr, L. C. (2021) · Science · doi:10.1126/science.abd9149 · Cited by 1,543
Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review
Djupesland, P. G. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0108-9 · Cited by 563
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2
Dhand, R., & Li, J. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1263pp · Cited by 409
Aerobiology and Its Role in the Transmission of Infectious Diseases
Fernstrom, A., & Goldblatt, M. (2013) · Journal of Pathogens · doi:10.1155/2013/493960 · Cited by 363
Inhalation drug delivery devices: technology update
Garcia-Contreras, L., Ibrahim, M., & Verma, R. (2015) · Medical Devices: Evidence and Research · doi:10.2147/mder.s48888 · Cited by 306
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Borghardt, J. M., Kloft, C., & Sharma, A. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/2732017 · Cited by 304
EAACI Molecular Allergology User's Guide 2.0
Dramburg, S., Hilger, C., Santos, A. F., de las Vecillas, L., Aalberse, R. C., Acevedo, N., Aglas, L., Altmann, F., Arruda, K. L., Asero, R., et al. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.13854 · Cited by 298
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre
Conway, S., Balfour-Lynn, I. M., De Rijcke, K., Drevinek, P., Foweraker, J., Havermans, T., Heijerman, H., Lannefors, L., Lindblad, A., Macek, M., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.009 · Cited by 232
Climate change, air quality, and respiratory health: a focus on particle deposition in the lungs
Chang, J.-H., Lee, Y.-L., Chang, L.-T., Chang, T.-Y., Hsiao, T.-C., Chung, K. F., Ho, K. F., Kuo, H.-P., Lee, K.-Y., Chuang, K.-J., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2264881 · Cited by 49
Metadata
- Authors
- Darquenne, C.
- Venue
- Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Publisher
- SAGE Publications
- Published
- 2012-06
- Volume
- 25
- Issue
- 3
- Pages
- 140-147
- ISSN
- 1941-2703 (ISSN-L)
- 1941-2711
- OpenAlex
- W2040017474
- Cited by
- 452
- References
- 27
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.